Bright Angel Therapeutics logo

Bright Angel Therapeutics

Targeting Antifungal Resistance

4 employees · est. 2017 · Toronto, Canada

VS
Genprex, Inc. logo

Genprex, Inc.

Genprex is a gene therapy company focused on developing life-changing technologies for patients with cancer & diabetes.

24 employees · est. 2009 · Austin, United States

Genprex, Inc. is the older company (2017 vs 2009); Genprex, Inc. is the larger of the two.

Side-by-Side Comparison

Bright Angel Therapeutics Genprex, Inc.
Founded
2017 2009 older
Headquarters
Toronto, Canada Austin, United States
Employees
4 24 larger
Industry
Biotechnology Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Seed Post Ipo Equity
Total Funding
$200.00K $89.40M
Funding Rounds
5 10
Services
Development of novel therapeutics for drug-resistant fungal infections, Design and development of fungal-selective inhibitors, Computational drug discovery using Schrödinger’s platform Not tracked yet
Target Customers
Healthcare providers managing drug-resistant fungal infections, Patients with compromised immune functions, Medical research institutions focused on infectious diseases, Pharmaceutical companies seeking antifungal assets Not tracked yet
Taxonomy
Antifungal Resistance, Drug Development, Therapeutics, Toronto-based Company Gene Therapy, Cancer Treatment, Diabetes Treatment, Clinical-stage Company, Disease-fighting Genes, Innovative Technology, Drug Candidates, Pipeline Development, Collaborative Partnerships
Website
brightangeltherapeutics.com genprex.com
Bright Angel Therapeutics logo

About Bright Angel Therapeutics

Bright Angel Therapeutics, headquartered in Canada, is a promising player in the Biotechnology sector. Founded in 2017, the company is addressing a critical issue in the realm of healthcare: resistance to existing antifungal treatments. With the mission encapsulated in their slogan, "Targeting Anti...

Genprex, Inc. logo

About Genprex, Inc.

Genprex is a biopharmaceutical startup founded in 2009, dedicated to pioneering life-altering therapies for cancer and diabetes through advanced gene therapy technologies. The company's innovative approach targets the delivery of disease-fighting genes, with the aim of creating new and effective tre...

We will tell you when either one moves

BounceWatch watches Bright Angel Therapeutics and Genprex, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Bright Angel Therapeut... and Genprex, Inc. — by email.

Frequently Asked Questions

Bright Angel Therapeutics — Targeting Antifungal Resistance. Genprex, Inc. — Genprex is a gene therapy company focused on developing life-changing technologies for patients with cancer & diabetes.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Bright Angel Therapeutics has raised $200.00K while Genprex, Inc. has raised $89.40M.
Bright Angel Therapeutics and Genprex, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Bright Angel Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Bright Angel Therapeutics on 9 Jun 2026, and Genprex, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes